Altimmune (ALT) FCF Margin Growth (5y) (2015 - 2025)
Powered by 
Analysis
Altimmune (ALT) FCF Margin Growth (5y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Altimmune | 628.10 Mn | 628.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -7.42 Mn |
| Sep 30, 2025 | -23.76 Mn |
| Jun 30, 2025 | -38.68 Mn |
| Mar 31, 2025 | -33.66 Mn |
| Dec 31, 2024 | -36.50 Mn |
| Sep 30, 2024 | -54.20 Mn |
| Jun 30, 2024 | -36.20 Mn |
| Mar 31, 2024 | -32.71 Mn |
| Dec 31, 2023 | -4.45 Mn |
| Sep 30, 2023 | -561,461.00 |
| Jun 30, 2023 | -32.30 Mn |
| Mar 31, 2023 | -9.25 Mn |
| Dec 31, 2022 | -6.64 Mn |
| Sep 30, 2022 | -75.54 Mn |
| Jun 30, 2022 | -20.88 Mn |
| Mar 31, 2022 | -4.12 Mn |
| Dec 31, 2021 | -54,039.00 |
| Sep 30, 2021 | -1.11 Mn |
| Jun 30, 2021 | -1.92 Mn |
| Mar 31, 2021 | -270,271.00 |